3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow COVI-VAC: new trials by email Literature Review of COVI-VAC trials Research Report on COVI-VAC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19 COVI-VAC - COVID-19, SARS-CoV-2 | Phase 1 | Completed | Codagenix, Inc | 20 | 2022-04-14 | 2023-01-13 |
| A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1) COVIVAC, Phosphate-buffered saline - COVID-19 Disease, SARS Pneumonia | Phase 1 | Completed | Institute of Vaccines and Medical Biologicals, Vietnam | 120 | 2021-03-10 | 2025-02-13 |
| Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19 COVI-VAC, Placebo - COVID-19 | Phase 1 | Completed | Codagenix, Inc | 48 | 2020-12-11 | 2022-06-28 |
COVID-19 (3) · Pneumonia, Viral (1)
Codagenix, Inc (2) · Institute of Vaccines and Medical Biologicals, Vietnam (1)
United Kingdom (2) · Vietnam (1)
Daryl Bendel, MD (1)